Cite
APA Citation
Jacquin, J. P., Uwer, L., Savignoni, A., Ferrero, J., Lortholary, A., Solub, D., Attar-Rabia, H., Deblay, S., Pibre, S., & Belkacemi, Y. (n.d.). 220PSefety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERMIONE non-interventional prospective study. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095496792.0x00003f